REVA Commences the RESTORE Clinical Trial First Human Implants With ReZolve(TM ... MarketWatch (press release) The RESTORE Trial (Pilot Study of the ReZolve Sirolimus-Eluting Bioresorbable Coronary Scaffold) will evaluate the safety and performance of ReZolve in 50 patients at multiple leading heart centers in Brazil and Europe. ReZolve is a fully bioresorbable ... |
